Literature DB >> 18611512

Quinolone pharmacokinetics.

R A Robson1.   

Abstract

Fluoroquinolones have broad antibacterial spectra and are active against most Gram-negative and many Gram-positive species. They exhibit excellent oral bioavailability, extensive tissue penetration, low protein binding, and a long elimination half-life. This review compares and contrasts the pharmakonetics of some quinolone antibiotics - especially pefloxacin, ciprofloxacin, enoxacin, norfloxacin, ofloxacin, fleroxacin and lomefloxacin - in terms of their adsorption, distribution, metabolism, elimination, and interactions with other drugs and with food. In addition, the pharmacokinetics of these agents in the elderly and in patients with renal or hepatic impairment is discussed. The fluoroquinolones are established as a major class of antibiotics in the treatment of infections but pharmacokinetics factors should be considered when deciding on the most appropriate of these agents to use in individual patients.

Entities:  

Year:  1992        PMID: 18611512     DOI: 10.1016/0924-8579(92)90020-r

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Effect of age and gender on the pharmacokinetics of grepafloxacin.

Authors:  C Efthymiopoulos; S L Bramer; A Maroli
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

2.  The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.

Authors:  M Kamberi; H Nakashima; K Ogawa; N Oda; S Nakano
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

3.  Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.

Authors:  C Efthymiopoulos; S L Bramer; A Maroli; J F Flaherty; E Wolfe; N Bass; K Somberg
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

4.  Effect of food and gastric pH on the bioavailability of grepafloxacin.

Authors:  C Efthymiopoulos; S L Bramer; A Maroli
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

5.  Effect of renal impairment on the pharmacokinetics of grepafloxacin.

Authors:  C Efthymiopoulos; S L Bramer; A Maroli; J G Gambertoglio
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

Review 6.  Quinolone antibacterials. An update of their pharmacology and therapeutic use.

Authors:  N von Rosenstiel; D Adam
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

7.  Old Drugs with New Tricks: Efficacy of Fluoroquinolones to Suppress Replication of Flaviviruses.

Authors:  Stacey L P Scroggs; Christy C Andrade; Ramesh Chinnasamy; Sasha R Azar; Erin E Schirtzinger; Erin I Garcia; Jeffrey B Arterburn; Kathryn A Hanley; Shannan L Rossi
Journal:  Viruses       Date:  2020-09-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.